Intracranial Meningeal Involvement in Churg-Strauss Syndrome

References

1. ↵
   Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angitis). Arthritis Rheum 1990;33:1094–1100

   CrossRefPubMedWeb of Science
2. ↵
   Jennette JC, Falk RJ. Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol 1995;101(suppl 1):18–22

   CrossRefPubMedWeb of Science
3. ↵
   Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurological manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995;70:337–341

   CrossRefPubMedWeb of Science
4. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984;63:65–81

   PubMedWeb of Science
5. ↵
   Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26–37

   CrossRefPubMedWeb of Science
6. ↵
   Liou HH, Liu HM, Chiang IP, Yeh TS, Chen RC. Churg-Strauss syndrome presented as multiple intracerebral hemorrhage. Lupus 1997;6:279–282

   Abstract/FREE Full Text
7. ↵
   Chang Y, Kargas SA, Goates JJ, Horoupian DS. Intraventricular and subarachnoid hemorrhage resulting from necrotizing vasculitis of the choroid plexus in a patient with Churg-Strauss syndrome. Clin Neuropathol 1993;12:84–87

   PubMedWeb of Science
8. ↵
   Kok J, Bosseray A, Brion JP, Micoud M, Besson G. Chorea in a child with Churg-Strauss syndrome. Stroke 1993;24:1263–1264

   FREE Full Text
9. ↵
   Hoffman GS, Kerr GS, Leavitt RY. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;16:488–498
10. Fausi AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76–85
11. ↵
    Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener’s granulomatosis: an analysis of 324 patients at the Mayo Clinic. Ann Neurol 1993;33:4–9

    CrossRefPubMedWeb of Science
12. ↵
    Murphy JM, Gomez-Anson B, Gillard JH, et al. Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 1999;213:794–799

    PubMedWeb of Science
13. ↵
    Drachman DA. Neurological complications of Wegener’s granulomatosis. Arch Neurol 1963;8:145–155

    CrossRefWeb of Science
14. ↵
    Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1–12

    PubMedWeb of Science
15. ↵
    Brijker F, Magee CC, Tervaert JW, O’Neill S, Walshe JJ. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 1999;52:344–351

    PubMedWeb of Science
16. ↵
    Cohen Tervaert JW, Huitema MG, Hene RJ, et al. Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709–711

    CrossRefPubMedWeb of Science